Boehringer Ingelheim: all 2,305 studies
Page 15 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female VolunteersCompletedNCT02273518Phase 1
- Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy SubjectsCompletedNCT02273505Phase 1
- Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy SubjectsCompletedNCT02273492Phase 1
- Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male VolunteersCompletedNCT02273479Phase 1
- Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male SubjectsCompletedNCT02273466Phase 1
- Study to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night TabletsCompletedNCT02273453Phase 1
- Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male VolunteersCompletedNCT02273440Phase 1
- Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male VolunteersCompletedNCT02273427Phase 1
- Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Doses of BIIL 284 BS in Healthy Male VolunteersCompletedNCT02273414Phase 1
- Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 11054 CL Administered With the Respimat® in Healthy Male VolunteersCompletedNCT02273401Phase 1
- Tolerability of Asasantin in Healthy Female and Male SubjectsCompletedNCT02269228Phase 1
- Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female VolunteersCompletedNCT02269215Phase 1
- Pharmacokinetics of Midazolam, With and Without Concomitant Administration of Crobenetine in Healthy Male SubjectsCompletedNCT02269202Phase 1
- Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) PatientsCompletedNCT02269189Phase 1
- Efficacy and Safety of Telmisartan and Losartan in Primary HypertensionCompletedNCT02269176Phase 3
- Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy VolunteersCompletedNCT02268773Phase 1
- Safety, Tolerance, and Pharmacokinetics of BILN 2061 ZW in Healthy Male Subjects, Combined With Preliminary Evaluation of Food EffectCompletedNCT02268760Phase 1
- Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy VolunteersTerminatedNCT02268604Phase 1
- Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male SubjectsCompletedNCT02268149Phase 1
- Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CLTerminatedNCT02268136Phase 1
- Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy VolunteersCompletedNCT02266550Phase 1
- Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male VolunteersCompletedNCT02266537Phase 1
- Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding DisordersCompletedNCT02266524Phase 1
- Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male SubjectsCompletedNCT02266511Phase 1
- Pharmacokinetics of BIBB 515 BS and Effect of Food After Oral Administration in Healthy SubjectsCompletedNCT02266498Phase 1
- Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 515 BS or Pravastatin in Hyperlipemic Healthy Male SubjectsCompletedNCT02266485Phase 1
- Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) PatientsCompletedNCT02265679Phase 1
- Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BSCompletedNCT02265666Phase 1
- Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy VolunteersCompletedNCT02265653Phase 1
- Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy VolunteersCompletedNCT02265640Phase 1
- Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy VolunteersCompletedNCT02265627Phase 1
- Safety, Tolerability, Biological Effects and Pharmacokinetics of BIIL 284 BS in Healthy MalesCompletedNCT02265302Phase 1
- Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male SubjectsCompletedNCT02265289Phase 1
- Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy SubjectsCompletedNCT02264197Phase 1
- Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male VolunteersCompletedNCT02264184Phase 1
- Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male VolunteersCompletedNCT02264171Phase 1
- Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy VolunteersCompletedNCT02264158Phase 1
- The Effect of Alcoholic-carrier Solutions Within Devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy VolunteersCompletedNCT02264145Phase 1
- Increasing Dose Study of Pramipexole in Two-way Cross-over Comparison of ER Tablet Versus IR Tablet in Japanese Healthy Male VolunteersCompletedNCT02264132Phase 1
- Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban in Healthy SubjectsCompletedNCT02264119Phase 1
- Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban Over 5 Days in Healthy SubjectsCompletedNCT02264106Phase 1
- Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male VolunteersCompletedNCT02264093Phase 1
- Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male VolunteersCompletedNCT02264080Phase 1
- Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male VolunteersCompletedNCT02264067Phase 1
- Pharmacokinetics of Talsaclidine After Administration to Healthy SubjectsCompletedNCT02264054Phase 1
- Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of CilobradineCompletedNCT02264041Phase 1
- Metabolism and Pharmacokinetics of [14C]-DK-AH 269 CL in 12 Healthy Male VolunteersCompletedNCT02264028Phase 1
- Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, to Healthy Male and Female Volunteers, With an Intra-individual Comparison to Moxifloxacin in a Subset of VolunteersCompletedNCT02264015Phase 1
- Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, Compared to Metoprolol Succinate and Placebo in Healthy VolunteersCompletedNCT02264002Phase 1
- Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male VolunteersCompletedNCT02263989Phase 1
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BEA 2180 BR in Healthy Male SubjectsCompletedNCT02263976Phase 1
- Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers IICompletedNCT02262858Phase 1
- Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male SubjectsCompletedNCT02262793Phase 1
- Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male VolunteersCompletedNCT02262780Phase 1
- Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female SubjectsCompletedNCT02262650Phase 1
- Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)CompletedNCT02262637
- Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male VolunteersCompletedNCT02262624Phase 1
- Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)CompletedNCT02262611
- Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male VolunteersCompletedNCT02262598Phase 1
- Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male VolunteersCompletedNCT02262585Phase 1
- Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male SubjectsCompletedNCT02262572Phase 1
- Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male VolunteersCompletedNCT02262559Phase 1
- Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female VolunteersCompletedNCT02262546Phase 1
- Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male VolunteersCompletedNCT02261129Phase 1
- Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy VolunteersCompletedNCT02261116Phase 4
- Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male VolunteersCompletedNCT02261103Phase 1
- Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male VolunteersCompletedNCT02261090Phase 1
- Pharmacokinetics, Safety and Tolerability of Rising Doses of Buscopan® in Healthy Male VolunteersCompletedNCT02261077Phase 1
- Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male VolunteersCompletedNCT02261064Phase 1
- Telmisartan in Mild to Moderate Hypertensive PatientsCompletedNCT02260089Phase 4
- Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human SubjectsCompletedNCT02260076Phase 1
- Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy VolunteersCompletedNCT02260063Phase 1
- Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male VolunteersCompletedNCT02260050Phase 1
- Dose Tolerance Study in Healthy Male Volunteers After Intranasal Application of Epinastine NasalCompletedNCT02260037Phase 1
- In Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets Pramipexole in Healthy Male VolunteersCompletedNCT02260024Phase 1
- Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02260011Phase 2
- Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male VolunteersCompletedNCT02259998Phase 1
- Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male SubjectsCompletedNCT02259985Phase 1
- Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male VolunteersCompletedNCT02259972Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male VolunteersCompletedNCT02259959Phase 1
- Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male VolunteersCompletedNCT02259946Phase 1
- Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male VolunteersCompletedNCT02259933Phase 1
- Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male VolunteersCompletedNCT02259920Phase 1
- Safety, Tolerability and Pharmacokinetics of KUC 7483 Tablets in Healthy Male VolunteersCompletedNCT02259907Phase 1
- Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male VolunteersCompletedNCT02259894Phase 1
- Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male VolunteersCompletedNCT02259881Phase 1
- Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer SubjectsCompletedNCT02259868Phase 1
- Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic ImpairmentCompletedNCT02259855Phase 1
- Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male VolunteersCompletedNCT02259842Phase 1
- Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female VolunteersCompletedNCT02259829Phase 1
- Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy VolunteersCompletedNCT02259816Phase 1
- Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male VolunteersCompletedNCT02259803Phase 1
- Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male VolunteersCompletedNCT02259790Phase 1
- Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female VolunteersCompletedNCT02259777Phase 1
- Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of KUC 7483 CL Tablets in Healthy Male VolunteersCompletedNCT02259764Phase 1
- Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor OveractivityCompletedNCT02259751Phase 1
- Metabolism and Pharmacokinetics of [14C] BEA 2180 BR Administered Orally Compared to [14C] BEA 2180 BR Administered Intravenously in Healthy Male VolunteersCompletedNCT02258971Phase 1
- Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir in Healthy Male VolunteersCompletedNCT02257021Phase 1
- Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male VolunteersCompletedNCT02257008Phase 1
- Study to Evaluate the Effect Single and Multiple Oral Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Amitriptyline and Nortriptyline in Healthy Male and Female SubjectsCompletedNCT02256878Phase 1